BLADDER CANCER CLINICAL GUIDELINES PANEL SUMMARY REPORT ON THE MANAGEMENT OF NONMUSCLE INVASIVE BLADDER CANCER (STAGES Ta, T1 AND TIS)

Abstract

No AccessJournal of UrologyCLINICAL UROLOGY: Special Communications1 Nov 1999BLADDER CANCER CLINICAL GUIDELINES PANEL SUMMARY REPORT ON THE MANAGEMENT OF NONMUSCLE INVASIVE BLADDER CANCER (STAGES Ta, T1 AND TIS) JOSEPH A. SMITH, RICHARD F. LABASKY, ABRAHAM T.K. COCKETT, JOHN A. FRACCHIA, JAMES E. MONTIE, and RANDALL G. ROWLAND JOSEPH A. SMITHJOSEPH A. SMITH , RICHARD F. LABASKYRICHARD F. LABASKY , ABRAHAM T.K. COCKETTABRAHAM T.K. COCKETT , JOHN A. FRACCHIAJOHN A. FRACCHIA , JAMES E. MONTIEJAMES E. MONTIE , and RANDALL G. ROWLANDRANDALL G. ROWLAND View All Author Informationhttps://doi.org/10.1016/S0022-5347(05)68208-0AboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookLinked InTwitterEmail Abstract Purpose: The American Urological Association convened the Bladder Cancer Clinical Guidelines Panel to analyze the literature regarding available methods of treating nonmuscle invasive bladder cancer, and to make practice policy recommendations based primarily on treatment outcomes data. Materials and Methods: The panel searched the MEDLINE database for all articles related to nonmuscle invasive bladder cancer published from 1966 to January 1998. Outcomes data were extracted from articles accepted after panel review and meta-analyzed to produce comparative probability estimates for alternative treatments. Results: All of the intravesical agents (thiotepa, bacillus Calmette-Guerin, mitomycin C and doxorubicin) when used as adjuvant therapy after transurethral resection resulted in a lower probability of recurrence compared to resection alone. However, there is no evidence that intravesical therapy affects long-term progression. Conclusions: For patients with no prior intravesical therapy adjuvant intravesical chemotherapy or immunotherapy is a treatment option after endoscopic removal of low grade Ta bladder cancers. Intravesical instillation of bacillus Calmette-Guerin or mitomycin C is recommended for carcinoma in situ, and after endoscopic removal of T1 and high grade Ta tumors. References 1 Smith, J. A., Labasky, R. F., Cockett, A. T. K., Fracchia, J. A., Montie, J. E. and Rowland, R. G.: Bladder Cancer Clinical Guidelines Panel: Report on the Management of Non-Muscle-Invasive Bladder Cancer (Stages Ta, T1 and Tis). Baltimore: American Urological Association, Inc., 1999. Google Scholar 2 : A Manual for Assessing Health Practices and Designing Practice Policies: the Explicit Approach. Philadelphia: American College of Physicians1992. Google Scholar 3 : The confidence profile method: a Bayesian method for assessing health technologies. Oper. Res.1989; 37: 210. Google Scholar 4 : A Bayesian method for synthesizing evidence: the confidence profile method. Int. J. Technol. Assess. Health Care1990; 6: 31. Google Scholar 5 : FAST*PRO. Software for Meta-Analysis by the Confidence Profile Method. San Diego: Academic Press, Harcourt Brace Jovanovich1992. Google Scholar © 1999 by American Urological Association, Inc.FiguresReferencesRelatedDetailsCited byBarlow L, McKiernan J and Benson M (2018) Long-Term Survival Outcomes with Intravesical Docetaxel for Recurrent Nonmuscle Invasive Bladder Cancer After Previous Bacillus Calmette-Guérin TherapyJournal of Urology, VOL. 189, NO. 3, (834-839), Online publication date: 1-Mar-2013.Lu Z, Yeh T, Wang J, Chen L, Lyness G, Xin Y, Wientjes M, Bergdall V, Couto G, Alvarez-Berger F, Kosarek C and Au J (2018) Paclitaxel Gelatin Nanoparticles for Intravesical Bladder Cancer TherapyJournal of Urology, VOL. 185, NO. 4, (1478-1483), Online publication date: 1-Apr-2011.Pruthi R, Baldwin N, Bhalani V and Wallen E (2018) Conservative Management of Low Risk Superficial Bladder TumorsJournal of Urology, VOL. 179, NO. 1, (87-90), Online publication date: 1-Jan-2008.Huang G, Hamilton A, Lo M, Stein J and Penson D (2018) Predictors of Intravesical Therapy for Nonmuscle Invasive Bladder Cancer: Results From the Surveillance, Epidemiology and End Results Program 2003 Patterns of Care ProjectJournal of Urology, VOL. 180, NO. 2, (520-524), Online publication date: 1-Aug-2008.Hall M, Chang S, Dalbagni G, Pruthi R, Seigne J, Skinner E, Wolf J and Schellhammer P (2018) Guideline for the Management of Nonmuscle Invasive Bladder Cancer (Stages Ta, T1, and Tis): 2007 UpdateJournal of Urology, VOL. 178, NO. 6, (2314-2330), Online publication date: 1-Dec-2007.Abaza R, Keck R and Selman S (2018) Intraperitoneal Chemotherapy for the Prevention of Transitional Cell Carcinoma ImplantationJournal of Urology, VOL. 175, NO. 6, (2317-2322), Online publication date: 1-Jun-2006.MULLERAD M, BOCHNER B, ADUSUMILLI P, BHARGAVA A, KIKUCHI E, HUI-NI C, KATTAN M, CHOU T and FONG Y (2018) HERPES SIMPLEX VIRUS BASED GENE THERAPY ENHANCES THE EFFICACY OF MITOMYCIN C FOR THE TREATMENT OF HUMAN BLADDER TRANSITIONAL CELL CARCINOMAJournal of Urology, VOL. 174, NO. 2, (741-746), Online publication date: 1-Aug-2005.MARIAPPAN P and SMITH G (2018) A SURVEILLANCE SCHEDULE FOR G1Ta BLADDER CANCER ALLOWING EFFICIENT USE OF CHECK CYSTOSCOPY AND SAFE DISCHARGE AT 5 YEARS BASED ON A 25-YEAR PROSPECTIVE DATABASEJournal of Urology, VOL. 173, NO. 4, (1108-1111), Online publication date: 1-Apr-2005.KIPP B, KARNES R, BRANKLEY S, HARWOOD A, PANKRATZ V, SEBO T, BLUTE M, LIEBER M, ZINCKE H and HALLING K (2018) MONITORING INTRAVESICAL THERAPY FOR SUPERFICIAL BLADDER CANCER USING FLUORESCENCE IN SITU HYBRIDIZATIONJournal of Urology, VOL. 173, NO. 2, (401-404), Online publication date: 1-Feb-2005.MARTÍNEZ-PIÑEIRO J, MARTÍNEZ-PIÑEIRO L, SOLSONA E, RODRÍGUEZ R, FERNÁNDEZ GÓMEZ J, MARTÍN M, MOLINA J, COLLADO A, FLORES N, ISORNA S, PERTUSA C, RABADÁN M, ASTOBIETA A, CAMACHO J, ARRIBAS S and MADERO R (2018) HAS A 3-FOLD DECREASED DOSE OF BACILLUS CALMETTE-GUERIN THE SAME EFFICACY AGAINST RECURRENCES AND PROGRESSION OF T1G3 AND TIS BLADDER TUMORS THAN THE STANDARD DOSE? RESULTS OF A PROSPECTIVE RANDOMIZED TRIALJournal of Urology, VOL. 174, NO. 4 Part 1, (1242-1247), Online publication date: 1-Oct-2005.MUTO G, BARDARI F, D'URSO L and GIONA C (2018) SEMINAL SPARING CYSTECTOMY AND ILEOCAPSULOPLASTY: LONG-TERM FOLLOWUP RESULTSJournal of Urology, VOL. 172, NO. 1, (76-80), Online publication date: 1-Jul-2004.SNYDER C, HARLAN L, KNOPF K, POTOSKY A and KAPLAN R (2018) Patterns of Care for the Treatment of Bladder CancerJournal of Urology, VOL. 169, NO. 5, (1697-1701), Online publication date: 1-May-2003.BÖHLE A, JOCHAM D and BOCK P (2018) Intravesical Bacillus Calmette-Guerin Versus Mitomycin C For Superficial Bladder Cancer: A Formal Meta-Analysis of Comparative Studies on Recurrence and ToxicityJournal of Urology, VOL. 169, NO. 1, (90-95), Online publication date: 1-Jan-2003.COOKSON M, CHANG S, WELLS N, PAREKH D and SMITH J (2018) Complications of Radical Cystectomy For Nonmuscle Invasive Disease: Comparison With Muscle Invasive DiseaseJournal of Urology, VOL. 169, NO. 1, (101-104), Online publication date: 1-Jan-2003.SOLOWAY M, BRUCK D and KIM S (2018) Expectant Management of Small, Recurrent, Noninvasive Papillary Bladder TumorsJournal of Urology, VOL. 170, NO. 2, (438-441), Online publication date: 1-Aug-2003.LEE C, SMITH C, HALL J, WATERS W and BIERMANN J (2018) Bladder Cancer Facts: Accuracy of Information on the InternetJournal of Urology, VOL. 170, NO. 5, (1756-1760), Online publication date: 1-Nov-2003.GRIFFITHS T, CHARLTON M, NEAL D and POWELL P (2018) Treatment of Carcinoma In Situ With Intravesical Bacillus Calmette-Guerin Without MaintenanceJournal of Urology, VOL. 167, NO. 6, (2408-2412), Online publication date: 1-Jun-2002.Rajala P, Kaasinen E, Raitanen M, Liukkonen T and Rintala E (2018) Perioperative Single Dose Instillation of Epirubicin or Interferon-α After Transurethral Resection for The Prophylaxis of Primary Superficial Bladder Cancer Recurrence: A Prospective Randomized Multicenter Study—Finnbladder III Long-Term ResultsJournal of Urology, VOL. 168, NO. 3, (981-985), Online publication date: 1-Sep-2002.Herr H, Donat S and Dalbagni G (2018) Correlation of Cystoscopy With Histology of Recurrent Papillary Tumors of the BladderJournal of Urology, VOL. 168, NO. 3, (978-980), Online publication date: 1-Sep-2002.Soloway M, Sofer M and Vaidya A (2018) Contemporary Management Of Stage T1 Transitional Cell Carcinoma Of The BladderJournal of Urology, VOL. 167, NO. 4, (1573-1583), Online publication date: 1-Apr-2002.HERR H and SOGANI P (2018) DOES EARLY CYSTECTOMY IMPROVE THE SURVIVAL OF PATIENTS WITH HIGH RISK SUPERFICIAL BLADDER TUMORS?Journal of Urology, VOL. 166, NO. 4, (1296-1299), Online publication date: 1-Oct-2001.DUTTA S, SMITH J, SHAPPELL S, COFFEY C, CHANG S and COOKSON M (2018) CLINICAL UNDER STAGING OF HIGH RISK NONMUSCLE INVASIVE UROTHELIAL CARCINOMA TREATED WITH RADICAL CYSTECTOMYJournal of Urology, VOL. 166, NO. 2, (490-493), Online publication date: 1-Aug-2001.WAIDELICH R, STEPP H, BAUMGARTNER R, WENINGER E, HOFSTETTER A and KRIEGMAIR M (2018) CLINICAL EXPERIENCE WITH 5-AMINOLEVULINIC ACID AND PHOTODYNAMIC THERAPY FOR REFRACTORY SUPERFICIAL BLADDER CANCERJournal of Urology, VOL. 165, NO. 6 Part 1, (1904-1907), Online publication date: 1-Jun-2001.O'LEARY M, GEE W, HOLTGREWE H, BLUTE M, COOPER T, MILES B, NELLANS R, THOMAS R, PAINTER M, MEYER J, NASLUND M, GORMLEY E, BLIZZARD R and FENNINGER R (2018) 1999 AMERICAN UROLOGICAL ASSOCIATION GALLUP SURVEY: CHANGES IN PHYSICIAN PRACTICE PATTERNS, TREATMENT OF INCONTINENCE AND BLADDER CANCER, AND IMPACT OF MANAGED CAREJournal of Urology, VOL. 164, NO. 4, (1311-1316), Online publication date: 1-Oct-2000.THALMANN G, SERMIER A, RENTSCH C, MÖHRLE K, CECCHINI M and STUDER U (2018) URINARY INTERLEUKIN-8 AND 18 PREDICT THE RESPONSE OF SUPERFICIAL BLADDER CANCER TO INTRAVESICAL THERAPY WITH BACILLUS CALMETTE-GUERINJournal of Urology, VOL. 164, NO. 6, (2129-2133), Online publication date: 1-Dec-2000. Volume 162Issue 5November 1999Page: 1697-1701 Advertisement Copyright & Permissions© 1999 by American Urological Association, Inc.Keywordsbladder neoplasmsimmunotherapychemotherapy, adjuvantendoscopycarcinoma, transitional cellMetricsAuthor Information JOSEPH A. SMITH More articles by this author RICHARD F. LABASKY More articles by this author ABRAHAM T.K. COCKETT More articles by this author JOHN A. FRACCHIA More articles by this author JAMES E. MONTIE More articles by this author RANDALL G. ROWLAND More articles by this author Expand All Advertisement PDF downloadLoading ...